Preoperative Immunonutrition: Cost‐Benefit Analysis
Authors:
- Marco BragaMBMarco Braga
- Luca GianottiLGLuca Gianotti
- 1 January 2005
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 29 (1S) , S57-S61
Abstract
Background: To evaluate whether preoperative immunonutrition might lead to a savings in patient care. Data on resources consumed to treat postoperative complications are scanty, but morbidity costs continue to be a major burden for any health care system. A recent randomized clinical trial carried out in well-nourished patients with gastrointestinal cancer showed that a 5-day preoperative oral immunonutrition reduced postoperative morbidity compared with conventional treatment (no supplementation). Methods: The abovementioned trial was the basis for the economic evaluation. In-hospital related costs of routine surgical care and costs of nutrition were calculated. Estimates of complication costs were based on both resources used for treatment and additional length of hospital stay. Cost comparison and cost-effectiveness analysis were then carried out. Results: Total cost of nutrition was € 3407 in the conventional group and € 14,729 in the preoperative group. In patients without complication, the cost of in-hospital routine care was similar in both groups. The mean cost of complication was € 6178 in the conventional group and € 4639 in the preoperative group (p = .05). Total cost of patients with complications was € 535,236 in the conventional group and € 334,148 in the preoperative group. Total costs consumed 93% of the diagnosis-related-group (DRG) reimbursement rate in the conventional group and 78% in the preoperative group. Cost-effectiveness was € 6245 for the conventional group and € 2985 for the preoperative group. Conclusions: The costs of postoperative morbidity consumed a large amount of the DRG reimbursement rate. Preoperative immunonutrition was cost-effective in our series.Keywords
This publication has 17 references indexed in Scilit:
- Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancerSurgery, 2002
- Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric PatientsJournal of Parenteral and Enteral Nutrition, 2002
- Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trialThe Lancet, 2001
- Outcome and Cost-effectiveness of Perioperative Enteral Immunonutrition in Patients Undergoing Elective Upper Gastrointestinal Tract SurgeryArchives of Surgery, 1999
- A Prospective, Randomized Clinical Trial on Perioperative Feeding With an Arginine‐, Omega‐3 Fatty Acid‐, and RNA‐Enriched Enteral Diet: Effect on Host Response and Nutritional StatusJournal of Parenteral and Enteral Nutrition, 1999
- Is infection control an academic study?Journal of Hospital Infection, 1999
- Immunosuppression and immunomodulation in surgical patientsCurrent Opinion in Critical Care, 1997
- Users' Guides to the Medical LiteratureJAMA, 1997
- Users' Guides to the Medical LiteratureJAMA, 1997
- Gut Function and Immune and Inflammatory Responses in Patients Perioperatively Fed With Supplemented Enteral FormulasArchives of Surgery, 1996